Dopamine receptor heteromeric complexes and their emerging functions

Progress in Brain Research

Volumn 211, Issue , 2014, Pages 183-200

  George, Susan R ^a   Kern, Andras ^b   Smith, Roy G ^b   Franco, Rafael ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Adenosine receptor; BRET; Confocal FRET; D1 receptor; D2 receptor; Dopamine receptor heteromer; Ghrelin receptor; Oligomerization; SRET

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR HETEROMER; CANNABINOID 1 RECEPTOR; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR HETEROMER; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR HETEROMER; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR HETEROMER; G PROTEIN COUPLED RECEPTOR; GHRELIN RECEPTOR; GHRELIN RECEPTOR HETEROMER; LEVODOPA; LIGAND; UNCLASSIFIED DRUG; DOPAMINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING ASSAY; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DYSKINESIA; ENZYME PHOSPHORYLATION; FOOD INTAKE; HEK293 CELL LINE; HORMONE RECEPTOR INTERACTION; HUMAN; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; SECOND MESSENGER; ANIMAL; BRAIN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; DOPAMINE; HUMANS; RECEPTORS, DOPAMINE; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

EID: 84904615131     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/B978-0-444-63425-2.00008-8     Document Type: Chapter

References (47)

1. Albizu L., Cottet M., Kralikova M., Stoev S., Seyer R., Brabet I., Roux T., Bazin H., Bourrier E., Lamarque L., et al. Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat. Chem. Biol. 2010, 6:587-594.
2. Armentero M.T., Pinna A., Ferré S., Lanciego J.L., Müller C.E., Franco R. Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease. Pharmacol. Ther. 2011, 132:280-299.
3. Bertran-Gonzalez J., Bosch C., Maroteaux M., Matamales M., Hervé D., Valjent E., Girault J.A. Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 2008, 28:5671-5685.
4. Bonaventura J., Rico A.J., Moreno E., Sierra S., Sánchez M., Luquin N., Farré D., Müller C.E., Martínez-Pinilla E., Cortés A., Mallol J., Armentero M.T., Pinna A., Canela E.I., Lluís C., McCormick P.J., Lanciego J.L., Casadó V., Franco R. l-DOPA-treatment in primates disrupts the expression of A2A adenosine-CB1 cannabinoid-D2 dopamine receptor heteromers in the caudate nucleus. Neuropharmacology 2013, 79C:90-100.
5. Bouvier M. Oligomerization of G-protein-coupled transmitter receptors. Nat. Rev. Neurosci. 2001, 2:274-286.
6. Canals M., Marcellino D., Fanelli F., Ciruela F., de Benedetti P., Goldberg S.R., Neve K., Fuxe K., Agnati L.F., Woods A.S., Ferré S., Lluis C., Bouvier M., Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J. Biol. Chem. 2003, 278:46741-46749.
7. Carriba P., Navarro G., Ciruela F., Ferré S., Casadó V., Agnati L., Cortés A., Mallol J., Fuxe K., Canela E.I., Lluís C., Franco R. Detection of heteromerization of more than two proteins by sequential BRET-FRET. Nat. Methods 2008, 5:727-733.
8. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
9. Ferré S., Baler R., Bouvier M., Caron M.G., Devi L.A., Durroux T., Fuxe K., George S.R., Javitch J.A., Lohse M.J., Mackie K., Milligan G., Pfleger K.D., Pin J.P., Volkow N.D., Waldhoer M., Woods A.S., Franco R. Building a new conceptual framework for receptor heteromers. Nat. Chem. Biol. 2009, 5:131-134.
10. Fetissov S.O., Meguid M.M., Sato T., Zhang L.H. Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2002, 283:R905-R910.
11. George S.R., O'Dowd B.F. A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors. Sci. World J. 2007, 7:58-63.
12. George S.R., O'Dowd B.F., Lee S.P. G-protein-coupled receptor oligomerization and its potential for drug discovery. Nat. Rev. Drug Discov. 2002, 1:808-820.
13. Ginés S., Hillion J., Torvinen M., Le Crom S., Casadó V., Canela E.I., Rondin S., Lew J.Y., Watson S., Zoli M., Agnati L.F., Verniera P., Lluis C., Ferré S., Fuxe K., Franco R. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:8606-8611.
14. González S., Moreno-Delgado D., Moreno E., Pérez-Capote K., Franco R., Mallol J., Cortés A., Casadó V., Lluís C., Ortiz J., et al. Circadian-related heteromerization of adrenergic and dopamine D[U+2084] receptors modulates melatonin synthesis and release in the pineal gland. PLoS Biol. 2012, 10:e1001347.
15. Grouselle D., Chaillou E., Caraty A., Bluet-Pajot M., Zizzari P., Tillet Y., Epelbaum J. Pulsatile cerebrospinal fluid and plasma ghrelin in relation to growth hormone secretion and food intake in the sheep. J. Neuroendocrinol. 2008, 20:1138-1146.
16. Guan X.M., Yu H., Palyha O.C., McKee K.K., Feighner S.D., Sirinathsinghji D.J., Smith R.G., Van der Ploeg L.H., Howard A.D. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res. Mol. Brain Res. 1997, 48:23-29.
17. Hasbi A., Fan T., Alijaniaram M., Nguyen T., Perreault M.L., O'Dowd B.F., George S.R. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21377-21382.
18. Hasbi A., O'Dowd B.F., George S.R. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms. Curr. Opin. Pharmacol. 2010, 10:93-99.
19. Hasbi A., O'Dowd B.F., George S.R. Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol. Brain 2011, 4:e26.
20. Hillion J., Canals M., Torvinen M., Casado V., Scott R., Terasmaa A., Hansson A., Watson S., Olah M.E., Mallol J., Canela E.I., Zoli M., Agnati L.F., Ibanez C.F., Lluis C., Franco R., Ferre S., Fuxe K. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. J. Biol. Chem. 2002, 277:18091-18097.
21. Holst B., Holliday N.D., Bach A., Elling C.E., Cox H.M., Schwartz T.W. Common structural basis for constitutive activity of the ghrelin receptor family. J. Biol. Chem. 2004, 279:53806-53817.
22. Jiang H., Betancourt L., Smith R.G. Ghrelin amplifies dopamine signaling by crosstalk involving formation of GHS-R/D1R heterodimers. Mol. Endocrinol. 2006, 20:1772-1785.
23. Johnson P.M., Kenny P.J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat. Neurosci. 2010, 13:635-641.
24. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., et al. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998, 396:674-679.
25. Kern A., Albarran-Zeckler R., Walsh H.E., Smith R.G. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 2012, 73:317-332.
26. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
27. Lee S.P., So C.H., Rashid A.J., Varghese G., Cheng R., Lanca A.J., O'Dowd B.F., George S.R. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem. 2004, 279:35671-35678.
28. Maurel D., Comps-Agrar L., Brock C., Rives M.L., Bourrier E., Ayoub M.A., Bazin H., Tinel N., Durroux T., Prezeau L., et al. Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat. Methods 2008, 5:561-567.
29. Milligan G. G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 2004, 66:1-7.
30. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br. J. Pharmacol. 2009, 158:5-14.
31. Missale C., Nash S., Robinson S., Jaber M., Caron M. Dopamine receptors: from structure to function. Physiol. Rev. 1998, 78:189-225.
32. Navarro G., Ferré S., Cordomi A., Moreno E., Mallol J., Casadó V., Cortés A., Hoffmann H., Ortiz J., Canela E.I., Lluís C., Pardo L., Franco R., Woods A.S. Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J. Biol. Chem. 2010, 285:27346-27359.
33. Ng J., Rashid A.J., So C.H., O'Dowd B.F., George S.R. Activation of calcium/calmodulin-dependent protein kinase II alpha in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 2010, 165:535-541.
34. O'Dowd B.F., Ji X., Nguyen T., George S.R. Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem. Biophys. Res. Commun. 2012, 417:23-28.
35. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci. 2007, 30:375-381.
36. Perreault M.L., Hasbi A., Alijaniaram M., Fan T., Varghese G., Fletcher P.J., Seeman P., O'Dowd B.F., George S.R. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia. J. Biol. Chem. 2010, 285:36625-36634.
37. Perreault M.L., Hasbi A., O'Dowd B.F., George S.R. The dopamine D1-D2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in basal ganglia. Front. Neuroanat. 2011, 5:e31.
38. Perreault M.L., Fan T., Alijaniaram M., O'Dowd B.F., George S.R. Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2. PLoS One 2012, 7:e33348.
39. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome?. Eur. J. Pharmacol. 2003, 480:125-131.
40. Pin J.P., Neubig R., Bouvier M., Devi L., Filizola M., Javitch J.A., Lohse M.J., Milligan G., Palczewski K., Parmentier M., Spedding M. International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol. Rev. 2007, 59:5-13.
41. Pinna A., Bonaventura J., Farré D., Sánchez M., Simola N., Mallol J., Lluís C., Costa J., Baqi Y., Müller C.E., Cortés A., McCormick P., Canela E.I., Martínez-Pinilla E., Lanciego J.L., Casadó V., Armentero M.T., Franco R. l-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies. Exp. Neurol. 2014, 253:180-191.
42. Rashid A.J., So C.H., Kong M.M., Furtak T., El-Ghundi M., Cheng R., O'Dowd B.F., George S.R. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:654-659.
43. Rashid A.J., O'Dowd B.F., Verma V., George S.R. Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol. Sci. 2007, 28:551-555.
44. So C.H., Verma V., Alijaniaram M., Cheng R., Rashid A.J., O'Dowd B.F., George S.R. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers. Mol. Pharmacol. 2009, 75:843-854.
45. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4679-4684.
46. Volkow N.D., Wang G.-J., Baler R.D. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn. Sci. 2011, 15:37-46.
47. Wren A.M., Seal L.J., Cohen M.A., Brynes A.E., Frost G.S., Murphy K.G., Dhillo W.S., Ghatei M.A., Bloom S.R. Ghrelin enhances appetite and increases food intake in humans. J. Clin. Endocrinol. Metab. 2001, 86:5992.